In RAD51, only intronic and UTR variants were identified which is in line with the previous studies where no cancer-predisposing mutations were identified among early-onset breast cancer patients (Lose et al. 2006; Rapakko et al. 2006; Le Calvez-Kelm et al. 2012). This evidence concerns the gene RAD51 and breast cancer.